Analysis of multi-strain infection of vaccinated and recovered population through epidemic model: Application to
1Department of Mathematics, Augusta University, Augusta, GA, United States of America.
Abstract:
In this work, an innovative multi-strain SV EAIR epidemic model is developed for the study of the spread of a multi-strain infectious disease in a population infected by mutations of the disease. The population is assumed to be completely susceptible to n different variants of the disease, and those who are vaccinated and recovered from a specific strain k (k ≤ n) are immune to previous and present strains j = 1, 2, ⋯, k, but can still be infected by newer emerging strains j = k + 1, k + 2, ⋯, n. The model is designed to simulate the emergence and dissemination of viral strains. All the equilibrium points of the system are calculated and the conditions for existence and global stability of these points are investigated and used to answer the question as to whether it is possible for the population to have an endemic with more than one strain. An interesting result that shows that a strain with a reproduction number greater than one can still die out on the long run if a newer emerging strain has a greater reproduction number is verified numerically. The effect of vaccines on the population is also analyzed and a bound for the herd immunity threshold is calculated. The validity of the work done is verified through numerical simulations by applying the proposed model and strategy to analyze the multi-strains of the COVID-19 virus, in particular, the Delta and the Omicron variants, in the United State.
Related Concept Videos
Steps in Outbreak Investigation
Statistical Methods for Analyzing Epidemiological Data
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Analysis of Population Pharmacokinetic Data
Viral Recombination
Principles of Disease Surveillance


